https://highthroughputscreenin....gs.com/index.php/ure
Successfully determining the genetic makeup of a total of 2853 patients was accomplished. Concerning genetic variations, the mutations -516GT and rs3745274 are significant findings. The -1456 position of the genome shows a change from thymine to cytosine in the genetic variant rs2054675. The new stroke and any bleeding event observed within 90 days constituted the primary criteria for assessing efficacy and safety. From a group of 2853 patients, 328 percent exhibited the character